Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

121
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
121

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT Trial.

Circulation·2026
Same author

Advancing in-hospital mortality prediction for acute myocardial infarction: An analysis from the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry.

American heart journal·2026
Same author

Advancing quality in post-acute cardiovascular and stroke care: Why national leadership and certification matter.

The American journal of medicine·2026
Same author

Post-acute cardiovascular and stroke care and the potential of certification programs: A 'Call to Action'.

The American journal of medicine·2026
Same author

SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization.

Journal of the Society for Cardiovascular Angiography & Interventions·2024
Same author

Impact of Social Determinants of Health on Predictive Models for Outcomes After Congenital Heart Surgery.

Journal of the American College of Cardiology·2024

相关实验视频

Updated: Jun 17, 2025

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.4K

皮肤冠状动脉干预后的短期死亡:患病率,危险因素和医院风险调整后的死亡率

Edward L Hannan1, Ye Zhong1, Kimberly Cozzens1

  • 1University at Albany, State University of New York, Albany, New York.

Journal of the Society for Cardiovascular Angiography & Interventions
|August 12, 2024
PubMed
概括

许多穿皮冠状动脉干预 (PCI) 死亡发生在医院出院后,特别是在风险较低的患者中. 监测放免后的结果对于准确的PCI质量评估和公开报告至关重要.

关键词:
30天死亡率30天死亡率出院后的死亡率.通过皮肤进行冠状动脉干预.

更多相关视频

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.2K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.6K

相关实验视频

Last Updated: Jun 17, 2025

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.4K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.2K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.6K

科学领域:

  • 心血管医学 心血管医学
  • 医疗保健服务研究 医疗服务研究
  • 提高质量 提高质量

背景情况:

  • 皮肤冠状动脉干预 (PCI) 后的术后死亡率尚不清楚.
  • 很大一部分死亡发生在患者出院后,影响了质量指标.

研究的目的:

  • 调查将出院后30天死亡人数纳入PCI质量衡量的影响.
  • 分析患者的风险因素和医院出院前后的死亡率.

主要方法:

  • 使用纽约州的PCI注册表来获取2015年1月至2017年11月的数据.
  • 检查了患者的风险因素和医院风险调整后的30天死亡率 (住院和出院后).

主要成果:

  • 1.55%的PCI患者 (2121) 在30天内死亡;34.4% (730) 的这些死亡发生在出院后.
  • 在非紧急病例中,56%的30天死亡发生在出院后.
  • 医院死亡率异常值显示,住院和总体 (住院加上出院后) 措施之间的重叠有限.

结论:

  • 在PCI后的早期死亡中,很大一部分发生在出院后,特别是在风险较低的个体中.
  • 包括出院后的死亡,显著影响了医院风险调整的死亡率评估和质量报告.
  • 仔细考虑包括这些死亡在质量指标中的好处和缺点是必不可少的.